Send us a text
Aduhelm was the first new Alzheimer's treatment approved by the FDA in 18 years. However, its approval proved to be exceptionally controversial, as many medical experts and doctors opposed the drug, due to the lack of evidence that it is actually effective in slowing memory loss.
In this episode, John and David discuss how Aduhelm got approved and the polarizing affect it is having on US healthcare as whole.
Visit us at www.caretalkpodcast.com
View this episode on YouTube: https://youtu.be/XGVC0E0XCxA
Follow us on the Health Podcast Network: https://bit.ly/3Glciwj
#healthcareindustry #healthcarepolicy #caretalkpodcast #aduhlem #alzheimers #medicare
Support the show
⚙️CareTalk: Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.
CareTalk: Healthcare. Unfiltered.